Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Blue Sky Uranium Extends Non-Brokered Private Placement July 18, 2025 Charbone Hydrogene annonce une mise-a-jour sur les reglements de dettes par emission d’unites July 18, 2025 Charbone Hydrogen Announces Updates on Units for Debts July 18, 2025
Charbone Hydrogene annonce une mise-a-jour sur les reglements de dettes par emission d’unites July 18, 2025
